Smallpox Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Condition:   SmallpoxInterventions:   Biological: IMVAMUNE;   Biological: IMVAMUNE;   Biological: IMVAMUNE;   Other: PlaceboSponsor:   Bavarian NordicCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 14, 2010 Category: Research Source Type: clinical trials

A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Condition:   SmallpoxInterventions:   Biological: IMVAMUNE;   Biological: IMVAMUNESponsor:   Bavarian NordicCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2009 Category: Research Source Type: clinical trials

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)
Conditions:   Smallpox;   Atopic DermatitisIntervention:   Biological: MVA (smallpox vaccine)Sponsors:   Sanofi;   Sanofi Pasteur, a Sanofi CompanyWithdrawn - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2006 Category: Research Source Type: clinical trials